NeuroBo Pharmaceuticals, Inc. (NRBO)
NASDAQ: NRBO · IEX Real-Time Price · USD
4.340
+0.040 (0.93%)
At close: Mar 27, 2024, 4:00 PM
4.400
+0.060 (1.38%)
After-hours: Mar 27, 2024, 4:12 PM EDT

NeuroBo Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020201920182017201620152014
Cash & Equivalents
33.3616.3910.0913.922.8518.4824.043.620.32
Cash & Cash Equivalents
33.3616.3910.0913.922.8518.4824.043.620.32
Cash Growth
103.60%62.42%-27.54%389.38%-84.61%-23.13%564.12%1041.96%-
Other Current Assets
0.170.20.590.20.960.530.710.020.01
Total Current Assets
33.5316.5810.6814.123.8119.0124.753.640.33
Property, Plant & Equipment
00.220.290.350.010000
Other Long-Term Assets
000000.010.010.850.02
Total Long-Term Assets
00.220.290.350.010.010.010.850.02
Total Assets
33.5316.810.9714.473.8219.0224.754.490.35
Accounts Payable
0.710.832.580.640.174.032.010.530.02
Current Debt
00.030.020.0201.3606.420.74
Other Current Liabilities
11.081.31.11.420.051.012.111.960.12
Total Current Liabilities
11.782.163.72.080.226.394.128.920.88
Long-Term Debt
00.050.070.090.148.68000
Other Long-Term Liabilities
000000000
Total Long-Term Liabilities
00.050.070.090.148.69000
Total Liabilities
11.782.23.772.180.3615.084.128.920.88
Total Debt
00.070.090.120.1410.0406.420.74
Debt Growth
--24.47%-18.97%-17.73%-98.60%--771.64%-
Retained Earnings
-95.8-81.83-66.54-36.87-15.55-60.47-27.06-12.39-0.58
Comprehensive Income
000.010.0100000
Shareholders' Equity
21.7514.67.212.29-13.293.9420.63-12.38-0.53
Net Cash / Debt
33.3616.321013.812.78.4424.04-2.8-0.42
Net Cash / Debt Growth
104.49%63.24%-27.61%410.61%-67.97%-64.88%---
Net Cash Per Share
103.71169.20147.93634.37152.664894.4924835.74-5853.86-1653.54
Working Capital
21.7514.436.9912.043.5912.6220.63-5.27-0.55
Book Value Per Share
67.61151.38106.61564.75-750.112285.0621311.06-25838.61-2093.91
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).